These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Proteasome inhibitors in pediatric cancer treatment. Bachmann AS Hawaii Med J; 2008 Sep; 67(9):247-9. PubMed ID: 18853901 [TBL] [Abstract][Full Text] [Related]
23. Telomerase as a diagnostic and therapeutic target for cancer. Doyle LA; Highsmith WE Expert Rev Anticancer Ther; 2002 Apr; 2(2):217-25. PubMed ID: 12113243 [TBL] [Abstract][Full Text] [Related]
25. Inhibitors of proteases as anticancer drugs. Jedinak A; Maliar T Neoplasma; 2005; 52(3):185-92. PubMed ID: 15875078 [TBL] [Abstract][Full Text] [Related]
26. Inhibitors of aspartic proteases in human diseases: molecular modeling comes of age. Hoegl L; Korting HC; Klebe G Pharmazie; 1999 May; 54(5):319-29. PubMed ID: 10368824 [TBL] [Abstract][Full Text] [Related]
27. Angiogenesis and surgery: from mice to man. Drixler TA; Voest EE; van Vroonhoven TJ; Borel Rinkes IH Eur J Surg; 2000 Jun; 166(6):435-46. PubMed ID: 10890539 [No Abstract] [Full Text] [Related]
28. Detection of an intracellular protease inhibitor in archaea. Giménez MI; Sánchez JJ; De Castro RE Curr Microbiol; 2003 May; 46(5):334-9. PubMed ID: 12732960 [TBL] [Abstract][Full Text] [Related]
29. New functions of stromal proteases and their inhibitors in tumor progression. Noel A; Albert V; Bajou K; Bisson C; Devy L; Frankenne F; Maquoi E; Masson V; Sounni NE; Foidart JM Surg Oncol Clin N Am; 2001 Apr; 10(2):417-32, x-xi. PubMed ID: 11382595 [TBL] [Abstract][Full Text] [Related]
30. Cancer biomarkers. Preface. Dixit R; Srivastava S Cancer Biomark; 2005; 1(1):3-4. PubMed ID: 17203571 [No Abstract] [Full Text] [Related]
31. GSIs described as most important finding in cancer-targeting research. Expert Rev Anticancer Ther; 2002 Dec; 2(6):617-8. PubMed ID: 12503199 [No Abstract] [Full Text] [Related]
32. Using kallikrein-related peptidases (KLK) as novel cancer biomarkers. Schmitt M; Magdolen V Thromb Haemost; 2009 Feb; 101(2):222-4. PubMed ID: 19190801 [No Abstract] [Full Text] [Related]
36. Cancer research. Taking garbage in, tossing cancer out? Garber K Science; 2002 Jan; 295(5555):612-3. PubMed ID: 11809952 [No Abstract] [Full Text] [Related]
37. Complex roles of tissue inhibitors of metalloproteinases in cancer. Jiang Y; Goldberg ID; Shi YE Oncogene; 2002 Mar; 21(14):2245-52. PubMed ID: 11948407 [TBL] [Abstract][Full Text] [Related]
38. Interactions of proteases, protease inhibitors, and the beta1 integrin/laminin gamma3 protein complex in the regulation of ectoplasmic specialization dynamics in the rat testis. Siu MK; Cheng CY Biol Reprod; 2004 Apr; 70(4):945-64. PubMed ID: 14645107 [TBL] [Abstract][Full Text] [Related]
39. Targeting proteases: successes, failures and future prospects. Turk B Nat Rev Drug Discov; 2006 Sep; 5(9):785-99. PubMed ID: 16955069 [TBL] [Abstract][Full Text] [Related]
40. [Therapeutic prospects of angiogenesis inhibitors in cancerology]. Bout JC; Soncin F; Vandenbunder B Rev Mal Respir; 1999 Nov; 16(5):854-5. PubMed ID: 10612161 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]